Jubilant Pharmova Ltd.
|
Balance Sheet
|
|
You can view the
Balance Sheet
for the last 5 years.
Market Cap. (Rs.)
|
13729.24 Cr.
|
P/BV
|
2.31
|
Book Value (Rs.)
|
372.96
|
52 Week High/Low (Rs.)
|
1310/617
|
FV/ML
|
1/1
|
P/E(X)
|
178.07
|
Bookclosure
|
02/08/2024
|
EPS (Rs.)
|
4.84
|
Div Yield (%)
|
0.58
|
|
(Rs. in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
No. of Equity Shares (in Lacs) | 1592.81 | 1592.81 | 1592.81 | 1592.81 | 1592.81 |
| | | | | |
EQUITIES AND LIABILITIES | | | | | |
SHAREHOLDER'S FUNDS | | | | | |
Equity Share Capital | 15.80 | 15.91 | 15.92 | 15.92 | 15.93 |
Total Share Capital | 15.80 | 15.91 | 15.92 | 15.92 | 15.93 |
| | | | | |
Reserves and Surplus | 5418.10 | 5383.37 | 5302.64 | 4725.57 | 5587.95 |
Total Reserves and Surplus | 5418.10 | 5383.37 | 5302.64 | 4725.57 | 5587.95 |
Total Shareholders Funds | 5433.90 | 5399.28 | 5318.56 | 4741.49 | 5603.88 |
Minority Interest | -12.80 | -7.49 | -2.16 | 0.03 | 0.00 |
| | | | | |
NON-CURRENT LIABILITIES | | | | | |
Long Term Borrowings | 3167.10 | 3110.36 | 2464.24 | 2563.97 | 3739.69 |
Deferred Tax Liabilities [Net] | 210.80 | 306.21 | 302.97 | 247.30 | 263.42 |
Other Long Term Liabilities | 760.40 | 483.64 | 219.99 | 222.48 | 144.90 |
Long Term Provisions | 100.10 | 92.25 | 95.67 | 94.01 | 150.75 |
Total Non-Current Liabilities | 4238.40 | 3992.46 | 3082.87 | 3127.76 | 4298.76 |
| | | | | |
CURRENT LIABILITIES | | | | | |
Short Term Borrowings | 247.00 | 299.72 | 463.37 | 20.00 | 649.89 |
Trade Payables | 856.30 | 821.32 | 567.74 | 520.48 | 1090.27 |
Other Current Liabilities | 719.30 | 573.02 | 473.65 | 418.54 | 780.09 |
Short Term Provisions | 66.40 | 78.35 | 86.84 | 89.81 | 98.77 |
Total Current Liabilities | 1889.00 | 1772.40 | 1591.60 | 1048.83 | 2619.01 |
| | | | | |
Total Capital And Liabilities | 11548.50 | 11156.65 | 9990.87 | 8918.11 | 12521.65 |
| | | | | |
ASSETS | | | | | |
NON-CURRENT ASSETS | | | | | |
Tangible Assets | 2434.80 | 2591.87 | 2499.27 | 2297.41 | 4023.86 |
Intangible Assets | 192.50 | 162.80 | 128.58 | 181.37 | 226.65 |
Capital Work-In-Progress | 1252.30 | 773.25 | 291.83 | 277.78 | 263.62 |
Intangible Assets Under Development | 850.80 | 788.24 | 797.74 | 619.21 | 504.77 |
Fixed Assets | 4730.40 | 4316.16 | 3717.42 | 3375.78 | 5018.90 |
Goodwill On Consolidation | 2463.90 | 2428.59 | 2242.75 | 2129.96 | 2089.46 |
Non-Current Investments | 42.20 | 256.42 | 238.60 | 240.96 | 69.36 |
Deferred Tax Assets [Net] | 232.70 | 227.44 | 161.27 | 154.71 | 211.24 |
Long Term Loans And Advances | 0.30 | 0.43 | 0.55 | 13.71 | 17.78 |
Other Non-Current Assets | 202.90 | 165.21 | 121.08 | 50.49 | 76.56 |
Total Non-Current Assets | 7672.40 | 7394.25 | 6481.68 | 5965.61 | 7483.30 |
| | | | | |
| | | | | |
CURRENT ASSETS | | | | | |
Inventories | 1289.60 | 1380.53 | 1254.87 | 1129.38 | 1845.38 |
Trade Receivables | 915.90 | 961.24 | 927.99 | 819.90 | 1293.22 |
Cash And Cash Equivalents | 956.80 | 1014.30 | 984.24 | 671.32 | 1399.87 |
Short Term Loans And Advances | 0.80 | 1.14 | 1.40 | 1.43 | 3.45 |
OtherCurrentAssets | 713.00 | 405.19 | 340.69 | 330.47 | 496.44 |
Total Current Assets | 3876.10 | 3762.40 | 3509.19 | 2952.50 | 5038.35 |
| | | | | |
Total Assets | 11548.50 | 11156.65 | 9990.87 | 8918.11 | 12521.65 |
| | | | | |
OTHER INFORMATION | | | | | |
| | | | | |
CONTINGENT LIABILITIES, COMMITMENTS | | | | | |
Contingent Liabilities | 1360.40 | 1256.59 | 842.82 | 887.12 | 1160.58 |
| | | | | |
BONUS DETAILS | | | | | |
Bonus Equity Share Capital | 4.40 | 4.40 | 4.40 | 4.40 | 4.40 |
| | | | | |
NON-CURRENT INVESTMENTS | | | | | |
Non-Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.43 |
Non-Current Investments Unquoted Book Value | 34.40 | 32.79 | 43.49 | 42.82 | 68.93 |